Skip to main content
Lincoln Pharmaceuticals ltd. logo

Lincoln Pharmaceuticals ltd. — Investor Relations & Filings

Ticker · LINCOLN ISIN · INE405C01035 LEI · 3358004B6OBJNW8RTT10 BSE.NS Manufacturing
Open in API
Filings indexed 453 across all filing types
Latest filing 2019-04-01 Regulatory Filings
Country IN India
Listing BSE.NS LINCOLN

About Lincoln Pharmaceuticals ltd.

https://www.lincolnpharma.com/

Lincoln Pharmaceuticals Ltd. focuses on the development, manufacturing, and marketing of a diverse range of therapeutic formulations. The organization operates advanced manufacturing facilities certified by international standards, including WHO-GMP. Its portfolio spans multiple areas such as anti-infectives, cardiovascular, gastrointestinal, respiratory, and pain management. The company is recognized for its research and development initiatives, particularly in Novel Drug Delivery Systems (NDDS). Key offerings include specialized treatments for tinnitus and a wide array of formulations in dosage forms like tablets, capsules, liquid orals, and injectables. It maintains a significant global footprint, supplying products to numerous international markets across Africa, Southeast Asia, and Latin America, supported by a robust distribution network for its extensive healthcare catalog.

Recent filings

Filing Released Lang Actions
Code of Conduct under SEBI(PIT) Reg., 2015
Regulatory Filings Classification · 90% confidence The document text is extremely short (658 characters) and consists mainly of addresses and titles related to stock exchanges and company officers. There is no substantive financial data, no mention of a report or filing type, no fiscal period, and no detailed content. It appears to be a brief communication or header information rather than a full report or announcement. Given the brevity and lack of report content, this fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous filings that do not fit other specific categories.
2019-04-01 English
Change in Auditors
Regulatory Filings Classification · 95% confidence The document text contains only placeholders for images and no substantive text content. The true document length is only 320 characters, which is very short and contains no financial data, report content, or announcements. Given the lack of any textual information or report content, this document cannot be classified as a full report or detailed filing. It is likely a placeholder or a minimal announcement. According to the rules, very short documents with no report content are best classified as Regulatory Filings (RNS) as a fallback category.
2019-03-28 English
Appointment
Regulatory Filings Classification · 90% confidence The document text contains only placeholders for images and no substantive text content. The true document length is only 320 characters, which is very short and contains no financial data, report content, or announcements. It does not contain any report, announcement, or certification text. Given the lack of content and the presence of only images, this document does not fit any specific report category and defaults to Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not fit elsewhere.
2019-03-28 English
Outcome of Board Meeting
Regulatory Filings Classification · 95% confidence The document is very short (622 characters) and appears to be a formal letter addressed to stock exchanges (BSE Limited and National Stock Exchange of India Limited) with scrip codes mentioned. There is no substantive financial data, no detailed report content, and no indication of financial results or management discussion. The content resembles a regulatory communication or announcement rather than a full report. Given the brevity and the nature of the addressees, this is likely a Regulatory Filing (RNS) rather than a full Annual Report, Interim Report, or other detailed filings.
2019-03-28 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2019-03-27 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is very short (700 characters) and appears to be a letter addressed to stock exchanges (National Stock Exchange of India Limited and BSE Limited) with scrip codes mentioned. There is no substantive financial data, no detailed report content, and no indication of financial statements or management discussion. The content resembles a regulatory communication or announcement rather than a full report. Given the brevity and the nature of the addressees, this is likely a Regulatory Filing (RNS) rather than a full report or announcement of voting results, capital changes, or other specific filings.
2019-03-26 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.